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27-Hydr~xych~~~tero~*~, 25-hy~oxycholesterol and choiesterol suppressed LDL uptake and degradation in human extrahepatic and hepatic cell 
lines in a concentrationdependent manner. Cholesterol was the least potent, and the inhibitory et&ct of oxysterols was more pronounced in skin 
fibroblasts and in endothelial cell line EAhy 926 than in hepatoma HepG2 cells. Shorter incubations were required for oxysterols to achieve 50% 
inhibition of LDL uptake and degradation in all cultured cells. The inhibition of LDL catabolism in extrahepatic ells by 27.hydroxycholesterol 
occurred at concentrations close to those observed in human plasma (0.2-0.6 PM). The results support a possible role of 27-hydroxycholesterol, 
a physiological oxysterol, in the regulation of cellular cholesterol homeostasis in non-hepatic tissues. 
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Oxygenated derivative(s) of cholesterol are believed 
to play a role in the regulation of cellular cholesterol 
homeostasis [l-5]. Oxysterols are potent inhibitors of 
HMG-CoA reductase activity and hence of cholesterol 
biosynthesis [1,3,6,7]. The possibility exists that the ac- 
tual modniator of cholesterol homeostasis is not 
cholesterol itself, but a more polar derivative either 
formed in the cell or produced by eeilular oxidation of 
lipoprotein cholesterol. The hypothesis that ex- 
ogenously added oxysterols are more potent inhibitors 
of HMG-CoA reductase because they more easily enter 
the cell and the regulatory pool of sterols than the less 
polar pure cholesterol cannot be ruled out. The demon- 
stration, however, that the addition of purified cholest- 
erol to cells does not influence HMG-CoA reductase 
activity [8,9], and the existence of a cytosolic binding 
protein for oxysterols but not for cholesterol [lO-131, 
attest the role of an oxygenated sterol(s) as regulator(s) 
of cholesterol synthesis. Perhaps, one of the most con- 
vincing evidences upporting this proposal is that keto- 
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conazole, a drug that inhibits ~~o~~orne P4se-depend- 
ent hydroxylations, when added in vitro to non-hepatic 
cells, prevents the ability of LDL, but not that of hy- 
droxysterols, to decrease the expression of LDL recep 
tors [14-161. These data suggest hat the physiological 
regulator of cholesterol homeostasis is likely to be an 
oxygenated cholesterol species formed in a cytochrome 
P,,,-catalyzed reaction. 25-Hydroxycholesterol and 27- 
hydroxycholesterol are among the most potent inhib- 
itors of the HMO-CoA reductase [1 3 17-191 and, in addi- 
tion, they decrease the receptor-mediated uptake and 
degradation of low density ~~prote~~ in cultured cells 
[17,20-22], thus interfering with both the endogenous 
and exo~nous supply of cholesterol to the cells. 2% 
Hydroxyeholesterol seems to be an autoxidation prod- 
uct of cholesterol and its presence in vivo is disputed 
[23-251. Several groups have suggested 27-hy 
droxycholesterol to be a likely candidate [l&22,26,27]. 
27-Hydroxycholesterol is synthesized from cholesterol 
by a cytochrome PhsO containing mitochondrial enzyme 
(C27-steroid 27-hydroxyla~) in most tissues [22,26,28], 
represents an intermediate in the synthesis of bile acids 
[22,29], is normally present in human plasma lipopro- 
tein [22,30] and in healthy and athero~lero~~ human 
aorta [31,32]. Recently, Saucier et al. [24], although not 
con&rmed by others [33], reported the presence of in- 
creased levels of oxysterols (24-, 25- and 27-hy- 
droxycholesterol) and repression of HMG-CoA reduc- 
tase in cholesterol fed-mice according to the hypothesis 
that intracellular oxysterols regulate the level of the 
reductase. 
Based on these premises, we compared the effect of 
25-, 27-hydroxycholesteroi and cholesterol on LDL re- 
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ceptor pathway in different human cell lines: skin fi- 
broblasts and the permanent endothelial cell line EAhy 
926 as models for extra-hepatic tissues, and the 
hepatoma cell line HepG2 as a model of liver parenchy- 
ma1 cells. 
2. MATERIALS AND METHODS 
NarsI, [3~holesteroi, [‘qoleic acid and [i4qNa-acetate were 
from Amersham (Amersham, UK); all cell culture media and fetal calf 
serum were from Gibco (Grand Island, NY, USA); bovine serum 
albumin, cholesterol and 25-hydroxycholesteroi were from Sigma (St. 
Louis, USA); 27-hydroxycholesterol was from Research Plus Inc. 
(Bayotme, NJ, USA); disposable sterile materials for cell cultures were 
from Coming (Corning, NY, USA). 
2.2. Cell culture 
Human skin fibroblasts were grown in monolayers from explants 
of skin biopsies obtained from normolipidemic linically healthy vol- 
unteers, and maintained at 37’C in a humidified atmostphere of 5% 
CO, in minimum essential medium supplemented with 10% FCS, 
non-essential amino acid solution (l%, v/v), penicillin (100 U/ml), 
st~ptomy~ (100 @ml), tricine buffer (20 mM, pH 7.4), NaHCO, 
(24 mM) [20]. The established human hepatoma cell line Hep G2 was 
obtained from American Type Culture Collection (Rockville, MD, 
USA). The cells were grown in monolayers and cultured as described 
for HSF [20] with the addition to the medium of 0.11 g/l of sodium 
pyruvate [34]. The permanent human cell line, EAhy 926, was kindly 
provided by Dr. C.J.S. Edgell (North Carolina, USA) and was cul- 
tured as described for HSF with the addition to the medium of 1% 
HAT (100 PM hypoxanthine, 0.4 PM aminopterin, 16 pM thymidine) 
[351. 
2.3. Low-&mit_v lipoproteins and lipoprotein-&$icient serm 
LDL (density 1.01~1.063 g/ml) were isolated from human serum 
by sequential preparative ~~~tifu~tion 1361, and were iodinated 
with ‘*q by the McFarlane [371 rnon~~o~de procedure as modified 
for lipoproteins by Bilheimer et al. [38]. Specific activity of the labeled 
LDL was 11 L-220 cpmlng protein and less than 2% of the radioactiv- 
ity was trichloroacetic acid-soluble. Lipoproteins were immediately 
sterilized by filtration and stored at 4°C until use. LPDS was prepared 
by ultraccntrifugation of human serum at density = 1.25 g/ml at 
40,000 rpm for 72 h, and sterilized by filtration [39]. 
2.4. Uptake and &gradation of [“‘I]LDL 
For all experiments, cells were seeded in 35 mm dishes (1.5 x lo5 for 
HSF and EAhy 926 cells and 5 x 10’ for Hep G2 cells) and used just 
before reaching confluency, usually 6 days after plating. Monolayers 
of cells were preincubated in a medium containing 5% lipoprotein- 
deficient m to up-regulate the LDL receptors, for the indicated 
times, in the presence or absence of sterols. Sterols were dissolved in 
ethanol (1% final ~n~nt~tion}; control cell dishes received the same 
volume of the solvent. The uptake (binding + ~temal~tion) of 
[i”IJLDL was evaluated as described by Goldstein et al. [40]. Briefly, 
after preincubation in a MEM containing 5% LPDS for the indicated 
times and concentrations of sterols, the cells were incubated with the 
same medium in the presence of [“‘I]LDL (7.5 ,@ml) for 5 h. After 
this time, monolayers were chilled on ice, the media were collected for 
the measurement of LDLdegradation and the cells were washed five 
times with cold phosphate buffered saline containing BSA 2 mglml 
and twice again with PBS. Then the cells were digested in 0.1 M NaOH 
and aliquots were taken for LDL uptake determination. LDL degra- 
dation was measured as the accumulation of non-iodide trichlo- 
roacetic acid-soluble “‘1 in the incubation medium in excess of that 
occurring in the absence of cells. Non specific uptake and degradation 
were determined by adding a 100-fold excess of unlabelled LDL 
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120,341. Cellular protein content was evaluated according to Lowry et 
al. [41]. The amount of sterols required to inhibit 50% of [‘251]LDL 
degradation by cultured cells was calculated by linear re8ression anal- 
ysis of the logarithm of the concentrations t&M) vs. probits and read 
from a probit transformation table [42]. 
3. RESULTS AND DISCUSSION 
In prelimina~ experiments the tested cell lines, incu- 
bated in the absence of sterols, showed a specific 
[“‘I]LDL uptake which was half-saturated at ligand 
concentrations of 12, 25 and 55 $g of lipoprotein pro- 
tein/ml for HSF, EAhy 926, and Hep G2 cells, respec- 
tively. In the presence of sterols, at concentrations rang- 
ing between 0.4 and 100 PM, the uptake and degrada- 
tion of [i2SI]LDL decreased and this effect was more 
pronounced in HSF and EAhy 926 than in Hep G2 cells 
(Fig. 1). This action of the tested sterols was dose-de- 
pendent with IC,, values, evaluated as LDL degrada- 
tion, of 0.02, 0.04 and 18 PM in endothelial cells and 
3.1, 19 and higher than 100 PM in HepG2 cells for 
25-OH-C, 27-OH-C and cholesterol, respectively. 
In addition, as shown in Fig. 2, shorter periods of 
incubation with oxysterols were required to achieve 
50% inhibition of [‘251]LDL uptake and degradation by 
all cultured cell lines. These results show that oxysterols 
are more potent and faster acting than cholesterol itself 
in modulating this process involved in cellular cholest- 
erol homeostasis. 
25-Hydroxycholesterol behaved as 27-hydroxychol- 
ester01 in inhibiting LDL receptor pathway in extra- 
hepatic cells, but was six times more potent than 27- 
hydroxy~holesterol in hepatic cells, as inferred from 
IC, values. The inability of low inundations of 27- 
OH-C to interfere with LDL uptake and degradation 
could be explained by the observation that oxysterols 
can be metabolized by 7o-hydroxylase to form bile acids 
[22,29]. It can be speculated that 7a-hydroxylase main- 
tains the expression of LDL receptors by metabolizing 
(i.e. inactivating) oxysterol repressor(s) [43]. Since Hep 
G2 cells are able to synthesize bile acids [44,45], and 
since 27-OH-C is a physiological bile acid precursor 
[22&l], part of this exogenously administered oxysterol 
can be utilized for this me~boli~ pathway and therefore 
it may not be completely available for regulating LDL 
receptors. This difference between the two oxysterols is 
in favor of a role, if any, of 27-OH-C in the regulation 
of cholesterol metabolism in extra-hepatic tissues; it has 
been, in fact, recently proposed that 27-OH-C is an 
intacrine regulator of sterol metabolism in ovarian cells 
[26]. A role for 27-OH-C as an effective modulator of 
cholesterol homeostasis in peripheral cells is consistent 
with the fact that the abundance of mRNA for 27- 
hydroxylase parallels the cholesterol biosynthetic ca- 
pacity in most tissues [27]. 
The shorter periods of incubation with oxysterols re- 
quired to achieve 50% i~ibition of LDL uptake and 
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Fig. 1. Effect of increasing concentrations of sterols on [‘251]LDL uptake and degradation by human hepatic (Hep G2) and extrahepatic (HSF; 
EAhy 926) cell lines. Cells were preincubated for 24 h at 37“C in MEM containing 5% LPDS in the presence of the indicated concentrations of 
sterols [‘?]LDL (7.5 @ml) were then added and the incubation continued for further 5 h at 37’C. Uptake and degradation of [‘?JLDL were 
determined as described in section 2. Each experimental point represents the mean + SD of three determinations. Cholesterol (0), 25-OH-C (O), 
27-OH-C (A). 
degradation could reflect a different rate of diffusion has been recently reported [21] than an analogue of 
into the cell. In fact cholesterol has to equilibrate with 27-hydroxycholesterol, 26aminocholestero1, that has 
a large membrane pool (about 90% of total cellular the same polarity of 27-hydroxycholesterol, possesses a
cholesterol) and must increase the cellular free cholest- similar ability in regulating cellular cholesterol homeo- 
erol content before eliciting its effect on the expression stasis. On the contrary another analogue, 26&a- 
of the genes regulating the synthesis of both LDL-recep- cholesterol, which is less polar than 27-hy- 
tor and HMG-CoA reductase [l]. Moreover, cholest- droxycholesterol and 26-aminocholesterol, is less effec- 
erol is less polar than its oxygenated erivatives and it tive in suppressing the expression of LDL-receptor [21]. 
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Fig. 2. Time-dependent effect of sterols on [‘*‘I]LDL uptake and degradation by HSF, EAhy 926 and Hep G2 cells. Cells were incubated for 24 h 
at 37°C in MEM containing 5% LPDS, sterols were then added and the incubation continued for the indicated times. A fixed concentration of 
[‘*‘I]LDL (7.5 fig/ml) was added and after 5 h the [‘=I]LDL uptake and degradation were determined as described in section 2. Each experimental 
point represents the mean f S.D. of three determinations. Cholesterol 100 pM (0) 25-OH-C 10 PM (O), 27-OH-C 10 PM (A). 
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These results suggest hat sterol polarity could be more 
important than the presence of an oxygenated function 
on the molecule. 
It should be mentioned that LDL-derived cholesterol 
exerts its effect before any increase in the overall cellular 
cholesterol content is detected [l]. This high physiologi- 
cal potency of LDL-derived cholesterol could be attri- 
buted to a carrier protein that binds cholesterol when 
it emerges from the lysosome and escorts it to regula- 
tory sites. Alternatively, lysosomally liberated cholest- 
erol could be converted into more active oxysterols [Z]. 
A protein that could mediate the regulatory action of 
oxysterols has been purified [lo,1 l] and its cDNA 
clones [12], although its metabolic role remains to be 
defined. Recently, Taylor [46] has shown that oxysterol 
potencies in the regulation of the degradation and the 
repression of HMG-CoA reductase were correlated 
with the relative affinities of oxysterols for an oxysterol 
binding protein, suggesting that this receptor is the ele- 
ment involved in both these regulatory pathways. 
In summary our data indiate that oxysterols are more 
efficient than cholesterol, in terms of potency and time, 
in i~biting the receptor mediated LDL pathway in 
h~an hepatic and extr~epati~ cell lines. The effect of 
27OH-C occurs in extrahepatic ells at concentrations 
similar to those observed in human serum (0.246 ,uM) 
[30], supporting a role of this physiologcal oxysterol in 
the regulation of cellular cholesterol homeostasis in ex- 
trahepatic tissues. 
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